ArticleFrontiers in cell and developmental biology2026
Single-cell multi-omics reveals circulating B cell heterogeneity across diverse disease contexts.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: B cells play essential roles in adaptive immunity by producing antigen-specific antibodies and interacting with T cells. Single-cell RNA and BCR sequencing technologies have enabled high-resolution dissection of B cell heterogeneity across diverse disease contexts. Atypical B cells (ABCs) display complex and critical functions in human immunity, yet their transcriptional heterogeneity, BCR diversity, and context-specific roles remain incompletely understood. Methods: In this study, we performed an integrative reanalysis of public single-cell RNA sequencing and single-cell B cell receptor (BCR) sequencing data derived from human peripheral blood mononuclear cells (PBMCs) across four distinct clinical contexts, including systemic lupus erythematosus (SLE), immunotherapy-treated melanoma, human immunodeficiency virus (HIV) blip, and age-stratified influenza vaccination. We established a unified analytical framework integrating transcriptomic profiling, BCR embedding-based clustering, and connectivity analysis to systematically characterize circulating B cell transcriptional features, BCR connectivity, and the correlation between transcriptomic and BCR diversity. Results: Our analysis revealed substantial dynamics in B cell transcriptomics and BCR repertoires across diverse time points and conditions. Notably, ABCs exhibited dynamic fluctuations, strong activation and BCR signaling, and marked transcriptomic diversity in response to autoreactive antigens, immunotherapy, transient viremia, and vaccination, positioning them as critical mediators of B cell responses. By integrating ABCs across all conditions, we identified nine distinct ABC clusters exhibiting specific transcriptional signatures associated with chemotaxis, complement activation, T cell regulation, plasma cell differentiation, or progenitor-like states. These ABC clusters displayed either phenotype-specific or shared distribution patterns, along with varying degrees of B cell activation, BCR signaling, and BCR connectivity across different phenotypes, suggesting divergent functional roles of ABCs. Discussion: Collectively, our cross-context analysis provides a broad characterization of circulating B cell heterogeneity, BCR diversity, and their associations in diverse conditions, advancing the understanding of ABC functional roles in human diseases. These findings highlight the potential of ABCs as key modulators of B cell responses across autoimmune, cancer, infection, and vaccine contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.